GPR55 and cancer: This is based on the finding that the cannabinoid CB2 receptor and the GPCR55 (GPR55) are overexpressed in cancer cells and human tumors and that they form heterodimers displaying antagonistic CB2-GPR55 interactions in cancer cells.